A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A British-made prostate cancer test could avoid the need for biopsies in four out of five cases, according to a study. The EpiSwitch PSE next generation blood test uses advances in technology to ...

Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive ...

Please provide your email address to receive an email when new articles are posted on . A urine-based test helped reduce unnecessary biopsies among men with prostate cancer. The test appeared to be ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...

A new blood test that looks for circulating tumor cells could significantly improve the diagnosis of prostate cancer and avoid unnecessary biopsies and treatments. A new blood test could help many ...